290 related articles for article (PubMed ID: 23973995)
1. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
[TBL] [Abstract][Full Text] [Related]
2. A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.
Ding W; Zhang S; Zhu M; Wang S; Xu T; Qu H; Yu T; Yan X; Wang Y
Anticancer Agents Med Chem; 2017; 17(4):566-575. PubMed ID: 27658994
[TBL] [Abstract][Full Text] [Related]
3. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
[TBL] [Abstract][Full Text] [Related]
4. Novel semisynthetic derivatives of betulin and betulinic acid with cytotoxic activity.
Santos RC; Salvador JA; Marín S; Cascante M
Bioorg Med Chem; 2009 Sep; 17(17):6241-50. PubMed ID: 19674909
[TBL] [Abstract][Full Text] [Related]
5. Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking.
Lan P; Chen WN; Huang ZJ; Sun PH; Chen WM
J Mol Model; 2011 Jul; 17(7):1643-59. PubMed ID: 20978914
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.
Shi W; Tang N; Yan WD
J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995
[TBL] [Abstract][Full Text] [Related]
7. New ionic derivatives of betulinic acid as highly potent anti-cancer agents.
Suresh C; Zhao H; Gumbs A; Chetty CS; Bose HS
Bioorg Med Chem Lett; 2012 Feb; 22(4):1734-8. PubMed ID: 22264477
[TBL] [Abstract][Full Text] [Related]
8. Lupane triterpenoids--betulin and betulinic acid derivatives induce apoptosis in tumor cells.
Kommera H; Kaluđerović GN; Kalbitz J; Paschke R
Invest New Drugs; 2011 Apr; 29(2):266-72. PubMed ID: 19957199
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.
Santos RC; Salvador JA; Marín S; Cascante M; Moreira JN; Dinis TC
Bioorg Med Chem; 2010 Jun; 18(12):4385-96. PubMed ID: 20494586
[TBL] [Abstract][Full Text] [Related]
10. Betulinic acid and its derivatives: a patent review (2008-2013).
Csuk R
Expert Opin Ther Pat; 2014 Aug; 24(8):913-23. PubMed ID: 24909232
[TBL] [Abstract][Full Text] [Related]
11. New ursolic and betulinic derivatives as potential cytotoxic agents.
Baglin I; Poumaroux A; Nour M; Tan K; Mitaine-Offer AC; Lacaille-Dubois MA; Chauffert B; Cavé C
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):111-7. PubMed ID: 12943194
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
[TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of NO-releasing Betulinic Acid Derivatives as Potential Anticancer Agents.
Liu J; Zhu Z; Tang J; Lin Q; Chen L; Sun J
Anticancer Agents Med Chem; 2017; 17(2):241-249. PubMed ID: 27671295
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and anti-tumor activity of novel betulinic acid derivatives.
Liu JH; Tang J; Zhu ZF; Chen L
J Asian Nat Prod Res; 2014 Jan; 16(1):34-42. PubMed ID: 24350921
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity.
Rajendran P; Jaggi M; Singh MK; Mukherjee R; Burman AC
Invest New Drugs; 2008 Feb; 26(1):25-34. PubMed ID: 17851638
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity of betulin and betulinic acid derived 30-oxo-amides.
Kozubek M; Hoenke S; Schmidt T; Deigner HP; Al-Harrasi A; Csuk R
Steroids; 2022 Jun; 182():109014. PubMed ID: 35314417
[TBL] [Abstract][Full Text] [Related]
17. Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation
Yang Y; Xie T; Tian X; Han N; Liu X; Chen H; Qi J; Gao F; Li W; Wu Q; Huo S; Gu Y; Dai Z; Wang P; Lei H
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093264
[TBL] [Abstract][Full Text] [Related]
18. The new esters derivatives of betulin and betulinic acid in epidermoid squamous carcinoma treatment - In vitro studies.
Drąg-Zalesińska M; Wysocka T; Borska S; Drąg M; Poręba M; Choromańska A; Kulbacka J; Saczko J
Biomed Pharmacother; 2015 May; 72():91-7. PubMed ID: 26054680
[TBL] [Abstract][Full Text] [Related]
19. Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid.
Tan JM; Karthivashan G; Arulselvan P; Fakurazi S; Hussein MZ
Drug Des Devel Ther; 2014; 8():2333-43. PubMed ID: 25429205
[TBL] [Abstract][Full Text] [Related]
20. A convergent synthesis of novel alkyne-azide cycloaddition congeners of betulinic acid as potent cytotoxic agent.
Dangroo NA; Singh J; Rath SK; Gupta N; Qayum A; Singh S; Sangwan PL
Steroids; 2017 Jul; 123():1-12. PubMed ID: 28435038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
